Collectively, our studies underscore the importance of future studies investigating efficacy of targeting cell surface GRP78 in ascites-enriched ovarian cancer stem-like cells to inhibit multidrug resistance, thus increasing chemotherapy efficacy. This evidence concerns the gene HSPA5 and ovarian carcinoma.